| Analysis | Metabolite Name | Measured Value | Units | Treament | Exposure |
|---|---|---|---|---|---|
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 199035 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 270940 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 292946 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 297184 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 319241 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 330477 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 332560 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 343815 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 372631 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 390515 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 391191 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 430199 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 607825 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 615694 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 622409 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 690589 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 755941 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 760182 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 772047 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 814268 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 820898 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 967073 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 985355 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 1012227 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 1030572 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 1117131 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 1598364 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | 1753992 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | Area under curve | Antibiotics | Air | |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | Area under curve | Antibiotics | Ozone | |
| Reversed phase LC-MS Negative | 1-palmitoyl-GPA (16:0) | Area under curve | Water | Ozone |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|